BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29956024)

  • 1. Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?
    Abat C; Fournier PE; Jimeno MT; Rolain JM; Raoult D
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1687-1697. PubMed ID: 29956024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.
    Abat C; Rolain JM; Dubourg G; Fournier PE; Chaudet H; Raoult D
    Clin Infect Dis; 2017 Aug; 65(suppl_1):S58-S63. PubMed ID: 28859341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections due to multidrug-resistant organisms following heart transplantation: Epidemiology, microbiology, and outcomes.
    Bhatt PJ; Ali M; Rana M; Patel G; Sullivan T; Murphy J; Pinney S; Anyanwu A; Huprikar S; Taimur S
    Transpl Infect Dis; 2020 Feb; 22(1):e13215. PubMed ID: 31765045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
    PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
    Magiorakos AP; Srinivasan A; Carey RB; Carmeli Y; Falagas ME; Giske CG; Harbarth S; Hindler JF; Kahlmeter G; Olsson-Liljequist B; Paterson DL; Rice LB; Stelling J; Struelens MJ; Vatopoulos A; Weber JT; Monnet DL
    Clin Microbiol Infect; 2012 Mar; 18(3):268-81. PubMed ID: 21793988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need new antibiotics?
    Rolain JM; Abat C; Jimeno MT; Fournier PE; Raoult D
    Clin Microbiol Infect; 2016 May; 22(5):408-15. PubMed ID: 27021418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France.
    Le Page S; Dubourg G; Baron SA; Rolain JM; Raoult D
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):395-407. PubMed ID: 30515637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria.
    Falagas ME; Bliziotis IA; Kasiakou SK; Samonis G; Athanassopoulou P; Michalopoulos A
    BMC Infect Dis; 2005 Apr; 5():24. PubMed ID: 15819983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset neonatal infections and bacterial multidrug resistance.
    Lima CSSDC; Lima HAR; Silva CSAGE
    Rev Paul Pediatr; 2023 May; 41():e2022068. PubMed ID: 37255111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria.
    Dinh A; Salomon J; Bru JP; Bernard L
    Scand J Infect Dis; 2012 Mar; 44(3):182-9. PubMed ID: 22176655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.
    ; Guan X; He L; Hu B; Hu J; Huang X; Lai G; Li Y; Liu Y; Ni Y; Qiu H; Shao Z; Shi Y; Wang M; Wang R; Wu D; Xie C; Xu Y; Yang F; Yu K; Yu Y; Zhang J; Zhuo C
    Clin Microbiol Infect; 2016 Mar; 22 Suppl 1():S15-25. PubMed ID: 26627340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of extensive drug-resistant (XDR) Acinetobacter baumanniiin the Clinical Center University of Sarajevo, Bosnia and Herzegovina.
    Dedeić-Ljubović A; Granov Đ; Hukić M
    Med Glas (Zenica); 2015 Aug; 12(2):169-76. PubMed ID: 26276655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinical and microbiological data on Acinetobacter baumannii strains assist the preauthorization of antibiotics at the patient level for an effective antibiotic stewardship program.
    Swe Swe-Han K; Mlisana KP; Pillay M
    J Infect Public Health; 2017; 10(5):608-616. PubMed ID: 28237694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
    Fernandes M; Vira D; Medikonda R; Kumar N
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):315-22. PubMed ID: 26537122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
    Tzialla C; Borghesi A; Pozzi M; Stronati M
    Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study.
    Basak S; Singh P; Rajurkar M
    J Pathog; 2016; 2016():4065603. PubMed ID: 26942013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey.
    Pereira SG; Marques M; Pereira J; Cardoso O
    Microb Drug Resist; 2015 Apr; 21(2):194-200. PubMed ID: 25372011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Piano S; Singh V; Caraceni P; Maiwall R; Alessandria C; Fernandez J; Soares EC; Kim DJ; Kim SE; Marino M; Vorobioff J; Barea RCR; Merli M; Elkrief L; Vargas V; Krag A; Singh SP; Lesmana LA; Toledo C; Marciano S; Verhelst X; Wong F; Intagliata N; Rabinowich L; Colombato L; Kim SG; Gerbes A; Durand F; Roblero JP; Bhamidimarri KR; Boyer TD; Maevskaya M; Fassio E; Kim HS; Hwang JS; Gines P; Gadano A; Sarin SK; Angeli P;
    Gastroenterology; 2019 Apr; 156(5):1368-1380.e10. PubMed ID: 30552895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.